The global artificial intelligence in genomics market size was US$ 471 million in 2021. The global artificial intelligence in genomics market size is forecast to reach US$ 18,213 million by 2030, growing at a compound annual growth rate (CAGR) of 50.2% during the forecast period from 2022 to 2030.
The application of artificial intelligence (AI) in genomics focuses on the creation of computer systems that are capable of carrying out tasks like genome mapping. Additionally, AI makes it possible to investigate genetic material's structure, evolution, and function more quickly than it would be possible without human interaction. A primary goal of AI algorithms is to emulate human intelligence through genomic analysis, which includes genome annotation, variant calls, phenotype-to-genotype correspondences, and genome annotation. Furthermore, with minimal feature hand-crafting, AI techniques can directly predict DNA or protein structure.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. The COVID-19 pandemic has accelerated the development of new computing solutions that hasten the scope of understanding, severity, and illness rate. Technology, research, and the healthcare sector have been working together to create these new computing solutions. The implementation of AI in genomic sequences for diagnostics and medication development has also accelerated the growth of the global market.
Regional Analysis
North America accounted for a significant market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing adoption of artificial intelligence in genome sequencing and rising awareness among regional biotech & pharma companies. In addition, the existence of a huge patient population due to the rising high geriatric population and growing prevalence of chronic diseases has resulted in the increasing adoption of AI-based technology in the healthcare sector. Thus, these factors drive the global market.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the rising uses of AI across various applications like agriculture, animal research, diagnostics, and drug discovery. In addition, the existence of several top research organizations and the increasing demand for AI technology. Thus, these factors boost the global market growth.
Leading Competitors
The leading prominent companies profiled in the global artificial intelligence in genomics market are:
Scope of the Report
The global artificial intelligence in genomics market segmentation focuses on Offering, Technology, Functionality, Application, End-User, and Region.
Segmentation based on Offering
Segmentation based on Technology
Segmentation based on Functionality
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING
5.1 OVERVIEW
5.2 SOFTWARE
5.3 SERVICES
6 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 MACHINE LEARNING
6.2.1 DEEP LEARNING
6.2.2 SUPERVISED LEARNING
6.2.3 REINFORCEMENT LEARNING
6.2.4 UNSUPERVISED LEARNING
6.2.5 OTHER MACHINE LEARNING TECHNOLOGIES
6.3 COMPUTER VISION
7 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY
7.1 OVERVIEW
7.2 GENOME SEQUENCING
7.3 GENE EDITING
7.4 CLINICAL WORKFLOWS
7.5 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE
8 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 AGRICULTURE & ANIMAL RESEARCH
8.3 DIAGNOSTICS
8.4 PRECISION MEDICINE
8.5 DRUG DISCOVERY & DEVELOPMENT
8.6 OTHER APPLICATIONS
9 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END-USER
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECH COMPANIES
9.3 HEALTHCARE PROVIDERS
9.4 ACADEMIC INSTITUTES
9.5 RESEARCH CENTERS
9.6 GOVERNMENT ORGANIZATIONS
9.7 OTHER END-USERS
10 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO
10.3 EUROPE
10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA
11 GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES
12 COMPANY PROFILES
12.1 BENEVOLENTAI
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS
12.2 CAMBRIDGE CANCER GENOMICS
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS
12.3 DATA4CURE INCORPORATED
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS
12.4 DEEP GENOMICS
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS
12.5 FABRIC GENOMICS INCORPORATED
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS
12.6 FREENOME HOLDINGS, INCORPORATED
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS
12.7 GENOOX LIMITED
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS
12.8. IBM
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS
12.9 LIFEBIT MICROSOFT
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS
12.10 MOLECULARMATCH INCORPORATED
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS
12.11 NVIDIA CORPORATION
12.11.1 OVERVIEW
12.11.2 FINANCIAL PERFORMANCE
12.11.3 PRODUCT OUTLOOK
12.11.4 KEY DEVELOPMENTS
12.12 PRECISIONLIFE LIMITED
12.12.1 OVERVIEW
12.12.2 FINANCIAL PERFORMANCE
12.12.3 PRODUCT OUTLOOK
12.12.4 KEY DEVELOPMENTS
12.13 SOPHIA GENETICS
12.13.1 OVERVIEW
12.13.2 FINANCIAL PERFORMANCE
12.13.3 PRODUCT OUTLOOK
12.13.4 KEY DEVELOPMENTS
12.14 VERGE GENOMICS
12.14.1 OVERVIEW
12.14.2 FINANCIAL PERFORMANCE
12.14.3 PRODUCT OUTLOOK
12.14.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved